[1]斯崇文.核苷类似物抗乙型肝炎病毒治疗的新进展[J].中华传染病杂志, 2005, 23 (Suppl1) ∶11-16.
|
[2]张斌, 董培玲, 丁惠国, 等.阿德福韦酯停用后致急性肝功能衰竭死亡[J].药物不良反应杂志, 2008, 10 (4) ∶289-290.
|
[3]中华医学会.病毒性肝炎防治方案[J].中华肝脏杂志, 2000, 8 (6) ∶324-329.
|
[4]中华医学会.肝衰竭诊疗指南[J].实用肝脏病杂志, 2006, 9 (6) ∶321-324.
|
[5]中华医学会.慢性乙型肝炎防治指南[J].胃肠病学, 2006, 11 (9) ∶550-557.
|
[6]Song BC, Suh DJ, Lee HC, et al.Hepatitis B e antigen serocon version after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea[J].Hepatology, 2000, 32 (4) ∶803-806.
|
[7]吴东刚, 冯岚.阿德福韦酯不当停药导致肝功能损伤16例分析[J].中国误诊学杂志, 2009, 9 (30) ∶7502-7503.
|
[8]杜以真, 张琴冈, 刘峰等.拉米夫定治疗慢性乙型肝炎停药后的复发病例分析[J].肝脏, 2004, 9 (1) ∶5-7.
|
[9]Honkoop P, de-Man RA, Niesters HG, et al.Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy[J].Hepatology, 2000, 32 (3) ∶635-639.
|
[10]慢性乙型肝炎抗病毒治疗专家共识专家委员会.慢性乙型肝炎抗病毒治疗专家共识[J].临床肝胆病杂志, 2010, 26 (2) ∶125-130.
|